causal
A new drug called finerenone cuts the risk of kidney failure and heart problems by about 15–20% in diabetics with early kidney damage — likely by reducing inflammation and scarring in the kidneys and blood vessels.
Evidence from Studies
No evidence studies found yet.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.